Search research articles
Contact Us
Filters
Showing results (11-20 of 132) with videos related to
Page
of 14
Sort By:
Current Opinion in Hematology
|
April 29, 2000
Cytokine therapy for myelodysplastic syndrome
G Seipelt, O G Ottmann, D Hoelzer
Annals of Hematology
|
March 4, 2003
Imatinib for relapsed BCR/ABL positive leukemias
O G Ottmann, B Wassmann, D Hoelzer
Leukemia
|
May 8, 1999
Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
W K Hofmann, O G Ottmann, D Hoelzer
Leukemia
|
February 12, 1999
Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
W K Hofmann, O G Ottmann, D Hoelzer
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1988
Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3
M Steffen, O G Ottmann, M A Moore
Onkologie
|
February 1, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study
A Ganser, O G Ottmann, G Schulz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 13, 2007
High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparations
S Pursche, O G Ottmann, G Ehninger, et al.
Leukemia
|
May 1, 1992
Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses
C Schardt, O G Ottmann, D Hoelzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1988
Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor
L M Pelus, O G Ottmann, K H Nocka
Seminars in Hematology
|
July 1, 1996
Myelodysplastic syndromes: clinical features
W K Hofmann, O G Ottmann, A Ganser, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 132) with videos related to
Sort By:
Page
of 14
Current Opinion in Hematology
|
April 29, 2000
Cytokine therapy for myelodysplastic syndrome
G Seipelt, O G Ottmann, D Hoelzer
Annals of Hematology
|
March 4, 2003
Imatinib for relapsed BCR/ABL positive leukemias
O G Ottmann, B Wassmann, D Hoelzer
Leukemia
|
May 8, 1999
Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
W K Hofmann, O G Ottmann, D Hoelzer
Leukemia
|
February 12, 1999
Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
W K Hofmann, O G Ottmann, D Hoelzer
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1988
Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3
M Steffen, O G Ottmann, M A Moore
Onkologie
|
February 1, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study
A Ganser, O G Ottmann, G Schulz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 13, 2007
High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparations
S Pursche, O G Ottmann, G Ehninger, et al.
Leukemia
|
May 1, 1992
Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses
C Schardt, O G Ottmann, D Hoelzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1988
Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor
L M Pelus, O G Ottmann, K H Nocka
Seminars in Hematology
|
July 1, 1996
Myelodysplastic syndromes: clinical features
W K Hofmann, O G Ottmann, A Ganser, et al.
Page
of 14